2014

CME Group Announces Approval of CME European Trade Repository

LONDON, Nov. 29, 2013 /PRNewswire/ -- CME Group, the world's leading and most diverse derivatives marketplace, announced today that the European Securities and Markets Authority (ESMA) has approved the CME European Trade Repository as a Trade Repository (TR) under the European Market Infrastructure Regulation (EMIR).

CME Group's multi-asset European (EU) trade repository, based in London, will accept submission of trades across all mandated derivative asset classes namely interest rates, FX, credit, commodities and equities. It will accept cleared and non-cleared, bilaterally settled, over the counter and exchange-traded derivatives executed on venues anywhere in the world. The reported data will be made available to the reporting entity itself, as well as relevant regulators, supervisors and authorities.

 "Trade reporting of derivatives transactions is one of the major requirements of the post-crisis G20 summit and our CME European Trade Repository will enable sell-side and buy-side clients to ensure they are fully compliant in the EU," said Jonathan Thursby, President, CME Global Repository Services.  "This European addition to our existing CME Swap Data Repository in the US means that we can help our global and regional customers fully comply with multi-jurisdictional reporting."

In conjunction with its approved TR, CME Group will offer a delegated reporting service to its EU customers to comply with EMIR.  By offering this service, CME Group is addressing the increasingly complex and burdensome reporting obligations its customers face by making it a straight through processing activity of the CME Group's global futures and swaps markets.

CME Group operates one of only three swap data repositories (SDR) which were authorised in November 2012 for reporting under the Dodd Frank Act in the US. The CME European Trade Repository has been built on this proven infrastructure with extensive reporting expertise, and provides a simplified, efficient and low-cost way for market participants to report trades and monitor their own risk exposure.

As the world's leading and most diverse derivatives marketplace, CME Group (www.cmegroup.com) is where the world comes to manage risk.  CME Group exchanges offer the widest range of global benchmark products across all major asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, metals, weather and real estate.  CME Group brings buyers and sellers together through its CME Globex® electronic trading platform and its trading facilities in New York and Chicago.  CME Group also operates CME Clearing, one of the world's leading central counterparty clearing providers, which offers clearing and settlement services across asset classes for exchange-traded contracts and over-the-counter derivatives transactions. These products and services ensure that businesses everywhere can substantially mitigate counterparty credit risk.

CME Group is a trademark of CME Group Inc. The Globe Logo, CME, Globex and Chicago Mercantile Exchange are trademarks of Chicago Mercantile Exchange Inc.  CBOT and the Chicago Board of Trade are trademarks of the Board of Trade of the City of Chicago, Inc.  NYMEX, New York Mercantile Exchange and ClearPort are registered trademarks of New York Mercantile Exchange, Inc.  COMEX is a trademark of Commodity Exchange, Inc.  KCBOT, KCBT and Kansas City Board of Trade are trademarks of The Board of Trade of Kansas City, Missouri, Inc.  All other trademarks are the property of their respective owners. Further information about CME Group (NASDAQ: CME) and its products can be found at www.cmegroup.com.

CME-G

SOURCE CME Group



RELATED LINKS
http://www.cmegroup.com

More by this Source


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.